THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 122,965 Value ($000) $2,301 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 130,151 Value ($000) $1,900 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 167,429 Value ($000) $1,847 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 155,429 Value ($000) $1,388 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 198,491 Value ($000) $1,868 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 191,329 Value ($000) $1,542 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 350,587 Value ($000) $2,973 Avg Close $9.03 Range $8.13 - $10.44

Q1 2024

Shares 330,962 Value ($000) $2,969 Avg Close $9.27 Range $8.21 - $11.71

Q4 2023

Shares 287,102 Value ($000) $3,227 Avg Close $10.06 Range $8.52 - $11.57

Q3 2023

Shares 170,938 Value ($000) $1,475 Avg Close $9.65 Range $8.25 - $10.59

Q2 2023

Shares 182,260 Value ($000) $1,886 Avg Close $11.04 Range $9.98 - $12.03

Q1 2023

Shares 140,261 Value ($000) $1,522 Avg Close $10.57 Range $9.25 - $11.52

Q4 2022

Shares 143,432 Value ($000) $1,609 Avg Close $10.51 Range $9.56 - $11.83

Q3 2022

Shares 151,510 Value ($000) $1,536 Avg Close $9.37 Range $7.53 - $11.00

Q2 2022

Shares 147,468 Value ($000) $1,336 Avg Close $9.21 Range $8.15 - $10.52

Q1 2022

Shares 148,387 Value ($000) $1,419 Avg Close $9.80 Range $7.71 - $13.17

Q4 2021

Shares 198,054 Value ($000) $2,189 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 250,219 Value ($000) $1,852 Avg Close $11.19 Range $6.10 - $15.01

Q2 2021

Shares 8,727,324 Value ($000) $126,720 Avg Close $18.78 Range $14.46 - $22.74

Q1 2021

Shares 7,464,202 Value ($000) $152,346 Avg Close $19.01 Range $16.46 - $21.21

Q4 2020

Shares 5,467,300 Value ($000) $97,154 Avg Close $17.95 Range $14.48 - $20.53

Q3 2020

Shares 4,727,592 Value ($000) $69,898 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 4,482,777 Value ($000) $94,093 Avg Close $25.69 Range $20.17 - $31.35

Q1 2020

Shares 4,167,523 Value ($000) $96,312 Avg Close $25.03 Range $16.86 - $31.54

Q4 2019

Shares 3,177,537 Value ($000) $82,267 Avg Close $19.43 Range $15.72 - $26.47

Q3 2016

Shares 190,950 Value ($000) $6,920 Avg Close $27.84 Range $21.97 - $37.14

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	122,965	$2,301	$16.59	$13.50 - $20.33
Q3 2025	130,151	$1,900	$12.64	$10.82 - $14.87
Q2 2025	167,429	$1,847	$9.72	$7.90 - $11.82
Q1 2025	155,429	$1,388	$9.31	$8.35 - $10.90
Q4 2024	198,491	$1,868	$9.10	$7.88 - $10.26
Q3 2024	191,329	$1,542	$8.66	$7.44 - $10.42
Q2 2024	350,587	$2,973	$9.03	$8.13 - $10.44
Q1 2024	330,962	$2,969	$9.27	$8.21 - $11.71
Q4 2023	287,102	$3,227	$10.06	$8.52 - $11.57
Q3 2023	170,938	$1,475	$9.65	$8.25 - $10.59
Q2 2023	182,260	$1,886	$11.04	$9.98 - $12.03
Q1 2023	140,261	$1,522	$10.57	$9.25 - $11.52
Q4 2022	143,432	$1,609	$10.51	$9.56 - $11.83
Q3 2022	151,510	$1,536	$9.37	$7.53 - $11.00
Q2 2022	147,468	$1,336	$9.21	$8.15 - $10.52
Q1 2022	148,387	$1,419	$9.80	$7.71 - $13.17
Q4 2021	198,054	$2,189	$8.72	$7.30 - $11.24
Q3 2021	250,219	$1,852	$11.19	$6.10 - $15.01
Q2 2021	8,727,324	$126,720	$18.78	$14.46 - $22.74
Q1 2021	7,464,202	$152,346	$19.01	$16.46 - $21.21
Q4 2020	5,467,300	$97,154	$17.95	$14.48 - $20.53
Q3 2020	4,727,592	$69,898	$18.73	$14.62 - $22.82
Q2 2020	4,482,777	$94,093	$25.69	$20.17 - $31.35
Q1 2020	4,167,523	$96,312	$25.03	$16.86 - $31.54
Q4 2019	3,177,537	$82,267	$19.43	$15.72 - $26.47
Q3 2016	190,950	$6,920	$27.84	$21.97 - $37.14